Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and agingCarolina Simioni, Luca M. Neri|Oncotarget|2018Cited by 510
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemiaCarolina Simioni, Alberto M. Martelli|Leukemia|2012Cited by 87
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivationCarolina Simioni, Luca M. Neri|Oncotarget|2014Cited by 62
The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional ChemotherapyCarolina Simioni, Luca M. Neri|Oncotarget|2013Cited by 59
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic LeukemiaCarolina Simioni, Luca M. Neri|Oncotarget|2016Cited by 24